Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XIENCE 28 USA Study

NCT03815175 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03815175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03815175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XIENCE 28 USA Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
February 25, 2019
Completion date
February 4, 2021
Enrollment
1,605 (actual)
Sites
111

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, bleeding disorder, coagulation disorder, coronary artery disease, hematological diseases, hemorrhagic stroke, ischemic stroke, renal insufficiency, thrombocytopenia